EcoDrugPlus

Cathepsin K-Like

Ensembl ID : ENSHCOG00000013303
Gene Symbol: LOC109512208
3 Cross references
235 Possible Orthologues:

Cathepsin L1-Like

Ensembl ID : ENSHCOG00000002979
Gene Symbol: LOC109514600
2 Cross references
183 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSHCOG00000019594
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSHCOG00000018804
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSHCOG00000021174
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSHCOG00000009933
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSHCOG00000012110
Gene Symbol: LOC109507782
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSHCOG00000012668
Gene Symbol: LOC109523501
3 Cross references
258 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSHCOG00000014944
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSHCOG00000000256
Gene Symbol: CHRM2
3 Cross references
195 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSHCOG00000017285
Gene Symbol: CHRM3
3 Cross references
187 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSHCOG00000018145
Gene Symbol: CHRM4
1 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).